Source:Eli Lilly and Company First Phase 3 retatrutide trial appears in a peer-reviewed journal TRANSCEND-T2D-1 was published in The Lancet the first and, so far, only Phase 3 retatrutide trial to be externally peer reviewed rather than reported only by the sponsor
Antioxidant supplements do not replace sunscreen, protective clothing, or dermatologist-recommended treatments
Larger Phase 3 studies will provide more robust data on efficacy, long-term safety, and tolerability including a more detailed understanding of adverse effects such as dizziness across broader and more diverse patient populations
A simple trick that supposedly works in days
What are Your Homocysteine Levels
In a study done in 15 patients with PD, 200 mg of GSH was given intranasally and showed that GSH levels did not only raise, but the levels remained high even 1 hour after administration